Filing Details
OCULAR THERAPEUTIX, INC (NASDAQ:OCUL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:OCUL
OCULAR THERAPEUTIX, INC (OCUL) Files Quarterly Report for Q0
Filing Details OCULAR THERAPEUTIX, INC (NASDAQ:OCUL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026. The Healthcare company…
Market Context
OCULAR THERAPEUTIX, INC's stock currently trades at $8.40 with a market capitalization of $2.5B.
The 10-Q provides OCULAR THERAPEUTIX, INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for OCULAR THERAPEUTIX, INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OCUL Stock Page
Frequently Asked Questions
Where can I read OCUL's SEC filings?
Browse all filings on our OCUL SEC filings page.
What types of SEC filings does OCULAR THERAPEUTIX, INC file?
Public companies like OCULAR THERAPEUTIX, INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
